Pseudomonas aeruginosa: Biology, Genetics and Promising New Treatments
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: 30 November 2026
Special Issue Editors
Interests: antimicrobial peptides (AMPs); exosomes; extracellular vesicles; cancer therapy; antimicrobial therapy
Special Issue Information
Dear Colleagues,
Pseudomonas aeruginosa is a ubiquitous opportunistic pathogen characterized by remarkable environmental adaptability, largely attributable to its extensive genome and diverse repertoire of virulence determinants. It predominantly affects immunocompromised individuals as well as patients with chronic pulmonary conditions and severe burn injuries, where it can establish persistent and difficult-to-treat infections. A comprehensive understanding of its physiology, metabolic versatility, and infection strategies is critical for the development of effective therapeutic interventions. In recent years, advances in the investigation of novel antimicrobial agents and vaccine candidates have provided promising avenues for alternative treatment strategies, offering renewed prospects for improved clinical management of P. aeruginosa infections.
In this context, this Special Issue aims to provide an updated overview of these topics while presenting novel research contributions in the field.
Prof. Dr. Chiara Falciani
Guest Editor
Dr. Tania Henriquez
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Pseudomonas aeruginosa
- metabolism
- biology
- genetics
- pathogenicity
- new vaccines and treatments
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
